Free shipping on all orders over $ 500

Paricalcitol

Cat. No. M4816

All AbMole products are for research use only, cannot be used for human consumption.

Paricalcitol Structure
Size Price Availability Quantity
1mg USD 175 In stock
5mg USD 550 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Paricalcitol has potential to reduce the proliferation of the immortalized human uterine fibroid cells.Paricalcitol activates the vitamin D receptorPricalcitol may be a potential candidate for effective, safe, and noninvasive medical treatment option for uterine fibroids.

Customer Product Validations & Biological Datas
Source Reprod Sci (2014). Figure 3. Paricalcitol
Method Immunohistochemical analyses
Cell Lines nude mice
Concentrations 300 ng/kg/d
Incubation Time 4 consecutive weeks
Results Paricalcitol treatment produced a 66% reduction in cell proliferation, whereas 1,25-dihydroxyvitamin D3 produced a 56% reduction
Source Reprod Sci (2014). Figure 1. Paricalcitol
Method proliferation assay
Cell Lines HuLM cells
Concentrations 10 nmol/L
Incubation Time 168 h
Results We found that after 24 hours of treatment, paricalcitol reduced HuLM cell proliferation up to 9%at a 10 nmol/L concentration (P < .05),whereas vitamin D3 reduced proliferation only by 1% at the same concentration, and the reduction was not significant
Protocol (for reference only)
Cell Experiment
Cell lines HuLM cells
Preparation method Once these cells were approximately 70% confluent in culture medium, the media were replaced by Dulbecco Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12; phenol free) supplemented with 10% charcoal-stripped FBS and 10 nmol/L estradiol and treated with various concentrations of paricalcitol and 1,25-dihydroxyvitamin D3 in the range of 10 pmol/L to 1000 nmol/L at different time intervals for up to 168 hours. The effects of paricalcitol and 1,25-dihydroxyvitamin D3 on HuLM cell proliferation were assessed using a CyQuant cell proliferation assay kit
Concentrations 10 pmol/L to 1000 nmol/L
Incubation time 168 h
Animal Experiment
Animal models Eker rat
Formulation Propylene glycol
Dosages 300 ng/kg/d
Administration i.p.
Chemical Information
Molecular Weight 416.64
Formula C27H44O3
CAS Number 131918-61-1
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Halder SK, et al. Reprod Sci. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.

Related Vitamin Products
Calcifediol

Calcifediol is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase.

Vitamin C (L-Ascorbic Acid)

Vitamin C (L-Ascorbic Acid) is a water-soluble vitamin indicated for the prevention and treatment of scurvy.

Lipoic acid

Lipoic acid is a class of compounds belonging to the B class vitamins and is the growth factor of yeast and some kinds of microorganisms.

Tacalcitol

Tacalcitol is a synthetic vitamin D3 analog.

Alfacalcidol

Alfacalcidol (1-hydroxycholecalciferol) is a vitamin D active metabolites, acts as a non-selective VDR activator medication, and widely be used in the management of osteoporosis.

  Catalog
Abmole Inhibitor Catalog




Keywords: Paricalcitol supplier, Vitamin, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.